XRCC3 and non-small cell lung carcinoma: In this systematic review and meta-analysis, we comprehensively evaluated the correlation between XRCC3 Thr241Met polymorphism and clinical outcomes (response rate, overall survival and progression-free survival) of advanced NSCLC patients receiving platinum-based chemotherapy.